Keyphrases
Pancreatic Neuroendocrine Tumors (pNETs)
100%
Neuroendocrine Tumor
65%
Von Hippel-Lindau Disease
60%
Tumor
55%
Cushing's Syndrome
51%
Multiple Endocrine Neoplasia Type 1 (MEN1)
45%
Pheochromocytoma
44%
Confidence Interval
37%
Odds Ratio
35%
Carney Complex
32%
Hypopituitarism
32%
68Ga-DOTATATE
32%
Von Hippel-Lindau
28%
DOTATATE
27%
Etiology
27%
Cushing's Disease
26%
All-cause Mortality
26%
Germ Cells
24%
Obesity
24%
Pituitary Adenoma
24%
Adenoma
23%
Prognostic Factors
22%
Adrenal Cushing Syndrome
22%
Hazard Ratio
22%
Disease Progression
22%
Genetic Modification
21%
Multivariable
21%
Prolactin
20%
Plasma Cortisol
20%
Prognostic Utility
20%
Peptide Receptor Radionuclide Therapy
20%
Paraganglioma
19%
Patient Management
19%
Primary Hyperparathyroidism (pHPT)
19%
Pancreatic NET
19%
Macroprolactinoma
18%
Working Diagnosis
18%
Pediatric
17%
High Risk
17%
Systemic Metabolism
17%
Hyperglycemia
16%
Blood Glucose
16%
Pathogenic Variants
16%
Erdheim-Chester Disease
16%
Gene mutation
16%
Prognostic Marker
16%
Endogenous Cushing's Syndrome
16%
Cortisol Measurement
16%
Coagulation Profile
16%
Diagnosis Management
16%
Medicine and Dentistry
Diseases
93%
Neuroendocrine Tumor
79%
Pancreas Islet Cell Tumor
72%
Neoplasm
66%
Cushing Syndrome
61%
Von Hippel-Lindau Disease
44%
Hydrocortisone
40%
Carney Complex
32%
Odds Ratio
31%
Gallium 68
31%
Pheochromocytoma
30%
Pituitary Adenoma
27%
Prevalence
26%
Hypopituitarism
25%
Germ Cell
25%
Multiple Endocrine Neoplasia Type I
25%
Prognostic Factor
23%
Disease Exacerbation
21%
Adenoma
21%
Gene Mutation
20%
Paraganglioma
20%
Hazard Ratio
19%
Primary Hyperparathyroidism
19%
Computer Assisted Tomography
18%
Maturity Onset Diabetes of the Young
17%
Urinary System
17%
Nesidioblastosis
17%
All Cause Mortality
16%
Hyperglycemia
16%
Body Mass Index
16%
Erdheim-Chester Disease
16%
Prolactinoma
16%
Endoplasmic Reticulum Stress
16%
Family History
15%
Hypothalamic-Pituitary-Adrenal Axis
15%
Hypothyroidism
14%
Pediatrics Patient
14%
Corticotropin
13%
Positron Emission Tomography-Computed Tomography
13%
Diabetes Mellitus
13%
Cancer
13%
Somatics
13%
Genetic Screening
12%
Multiple Endocrine Neoplasia
12%
Adrenal Gland
12%
Radionuclide Therapy
12%
Peptide Receptor
12%
Hypercortisolism
12%
Endocrine Tumor
11%
Diabetes
11%
